Commonwealth Equity Services
ANIP icon

Commonwealth Equity Services’s ANI Pharmaceuticals ANIP Stock Holding History

Commonwealth Equity Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
2,998
-497
-14% -$39.9K ﹤0.01% 3942
2026
Q1 		$269K Sell
3,495
-140
-4% -$10.9K ﹤0.01% 3734
2025
Q4 		$287K Sell
3,635
-3,188
-47% -$276K ﹤0.01% 3685
2025
Q3 		$625K Sell
6,823
-1,229
-15% -$100K ﹤0.01% 2992
2025
Q2 		$525K Sell
8,052
-5,497
-41% -$358K ﹤0.01% 3096
2025
Q1 		$907K Buy
13,549
+2,037
+18% +$122K ﹤0.01% 2533
2024
Q4 		$636K Sell
11,512
-276
-2% -$15.8K ﹤0.01% 2770
2024
Q3 		$703K Sell
11,788
-326
-3% -$19.9K ﹤0.01% 2612
2024
Q2 		$771K Sell
12,114
-750
-6% -$48.7K ﹤0.01% 2481
2024
Q1 		$889K Sell
12,864
-40
-0.3% -$2.42K ﹤0.01% 2341
2023
Q4 		$712K Sell
12,904
-249
-2% -$13.7K ﹤0.01% 2417
2023
Q3 		$764K Hold
13,153
– – ﹤0.01% 2261
2023
Q2 		$708K Sell
13,153
-475
-3% -$21.1K ﹤0.01% 2353
2023
Q1 		$541K Hold
13,628
– – ﹤0.01% 2487
2022
Q4 		$548K Buy
13,628
+500
+4% +$18.8K ﹤0.01% 2394
2022
Q3 		$421K Buy
13,128
+785
+6% +$26.9K ﹤0.01% 2557
2022
Q2 		$366K Buy
12,343
+100
+0.8% +$2.88K ﹤0.01% 2652
2022
Q1 		$344K Buy
12,243
+765
+7% +$28.5K ﹤0.01% 2852
2021
Q4 		$528K Buy
+11,478
New +$493K ﹤0.01% 2476
2017
Q1 		– Sell
-4,668
Closed -$283K – 2416
2016
Q4 		$283K Sell
4,668
-180
-4% -$11K ﹤0.01% 1807
2016
Q3 		$322K Buy
4,848
+279
+6% +$17.5K ﹤0.01% 1657
2016
Q2 		$255K Buy
+4,569
New +$222K ﹤0.01% 1776

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services's ANIP Position: Q2 2026 in Review

Commonwealth Equity Services reduced its ANI Pharmaceuticals (ANIP) stake by 14% in Q2 2026, selling an estimated $39.9K and leaving 2,998 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

Commonwealth Equity Services first reported a position in ANIP in Q2 2016 and has held it in 22 quarters since. The position peaked at $907K in Q1 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Commonwealth Equity Services held 2,998 shares of ANI Pharmaceuticals worth $248K as of Q2 2026.
  • Commonwealth Equity Services sold 497 ANI Pharmaceuticals shares in Q2 2026, an estimated $39.9K.
  • ANI Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3942 holding.
  • Commonwealth Equity Services first reported a position in ANI Pharmaceuticals in Q2 2016 and has held it in 22 quarters since.
  • Commonwealth Equity Services's ANI Pharmaceuticals position peaked at $907K in Q1 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.